| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 12/20/2001 | WO2001096546A2 Protein phosphatases |
| 12/20/2001 | WO2001096322A1 Diamino phenothiazine derivatives and composition comprising same |
| 12/20/2001 | WO2001096285A1 Beta-amino acid nitrile derivatives |
| 12/20/2001 | WO2001095935A1 Immunostimulatory nucleic acids for inducing a th2 immune response |
| 12/20/2001 | WO2001095934A2 The use of plant oil-bodies in vaccine delivery systems |
| 12/20/2001 | WO2001095919A2 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses |
| 12/20/2001 | WO2001095911A1 Protease inhibitors |
| 12/20/2001 | WO2001095909A1 New use as antihelmintics of albofungin and analogs |
| 12/20/2001 | WO2001058896A8 Benzoxazole derivatives as tnf and pde iv inhibitors |
| 12/20/2001 | WO2001049821A3 Th1 specific cd4 t cell lines and method for inducing them ex vivo |
| 12/20/2001 | WO2001040223A3 Aminoheterocyclylamides as pesticides and antiparasitic agents |
| 12/20/2001 | US20010053796 Culture of fish in water tank |
| 12/20/2001 | US20010053794 Ionic polymers as anti-infective agents |
| 12/20/2001 | US20010053764 Interleukin-1 inhibitors in the treatment of diseases |
| 12/20/2001 | CA2412353A1 Protease inhibitors |
| 12/20/2001 | CA2411965A1 The use of plant oil-bodies in vaccine delivery systems |
| 12/20/2001 | CA2410824A1 Diamino phenothiazine derivatives and composition comprising same |
| 12/20/2001 | CA2410610A1 Human kinases |
| 12/20/2001 | CA2409315A1 Protein phosphatases |
| 12/20/2001 | CA2396871A1 Immunostimulatory nucleic acids for inducing a th2 immune response |
| 12/19/2001 | EP1164138A1 Terpyridine-platinum (II) complexes |
| 12/19/2001 | EP1163909A2 Use of sugar ethers as immunity adjuvant in vaccine compositions, therapeutic compositions containing them and their use as vaccine |
| 12/19/2001 | EP1163364A1 Screening method involving mgdg synthase |
| 12/19/2001 | EP1163256A1 Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone |
| 12/19/2001 | EP1163255A1 50 human secreted proteins |
| 12/19/2001 | EP1163208A2 Caspase inhibitors and uses thereof |
| 12/19/2001 | CN1076349C Desoxycyclodepsipeptides and their use for combatting endoparasites |
| 12/19/2001 | CN1076204C Recombinant coccidiosis vaccines |
| 12/19/2001 | CN1076194C Pharmaceutical preparation |
| 12/18/2001 | US6331630 Dimeric arylisoquinoline alkaloids and derivatives thereof |
| 12/18/2001 | US6331552 Therapy and prophylaxis of inflammatory disorders, for example of rheumatoid arthritis, or of allergic disorders |
| 12/18/2001 | US6331304 Immunogenic composition comprising an attenuated form which is a strain of leishmania and which is transformed by a plasmid containing the gm-csf gene |
| 12/13/2001 | WO2001094415A2 Nuclear hormone receptor |
| 12/13/2001 | WO2001094391A2 Intracellular signaling proteins |
| 12/13/2001 | WO2001093906A1 Adjuvant composition comprising fha protein or fragment of fha protein in free form |
| 12/13/2001 | WO2001093885A1 Therapeutic agents - ii |
| 12/13/2001 | WO2001093884A1 Therapeutic agents - i |
| 12/13/2001 | WO2001093883A1 Therapeutic agents - iii |
| 12/13/2001 | WO2001093872A1 Use of organophosphorous hydroxamic acid derivatives for producing medicaments |
| 12/13/2001 | WO2001045735A3 Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another enteric pathogen |
| 12/13/2001 | WO2001026682A3 Modified plant viruses and methods of use thereof |
| 12/13/2001 | DE10127922A1 New organophosphorous-substituted hydroxamic acid compounds, useful as pre- or post-emergence selective herbicides in crops such as rice |
| 12/13/2001 | DE10027887A1 Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen Compounds having a sulfonamide group, these compounds and pharmaceutical compositions containing them |
| 12/13/2001 | CA2411596A1 Therapeutic agents - ii |
| 12/13/2001 | CA2411578A1 Adjuvant composition comprising fha protein or fragment of fha protein in free form |
| 12/13/2001 | CA2409392A1 Intracellular signaling proteins |
| 12/13/2001 | CA2408748A1 Nuclear hormone receptor |
| 12/12/2001 | EP1161415A2 N-cyanomethylamides as protease inhibitors |
| 12/12/2001 | EP1161240A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/12/2001 | EP1161232A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
| 12/12/2001 | CN1326460A B-membered azalides and their use as antibiotic agents |
| 12/12/2001 | CN1326442A Pesticides |
| 12/12/2001 | CN1326440A Piperdine CCR-3 receptor antagonists |
| 12/12/2001 | CN1326318A Antiparasitic formulations |
| 12/12/2001 | CN1075946C Process for preparing synergetic antimalarial-compound naphthoquine phosphate |
| 12/11/2001 | US6329374 Non-systemic control of parasites |
| 12/11/2001 | US6329345 13-membered azalides and their use as antibiotic agents |
| 12/11/2001 | US6328954 Use of the IL-4 receptor for the therapy prophylaxis and diagnosis of allergic viral parasitic and bacterial diseases and of fungal infections |
| 12/11/2001 | CA2213108C 2-aminobenzazapine derivatives |
| 12/06/2001 | WO2001092527A2 Regulators of apoptosis |
| 12/06/2001 | WO2001092321A2 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes |
| 12/06/2001 | WO2001092304A2 Transporters and ion channels |
| 12/06/2001 | WO2001092280A1 Hygromycin a derivatives for the treatment of bacterial and protozoal infections |
| 12/06/2001 | WO2001092218A2 Polyamine analogues as therapeutic and diagnostic agents |
| 12/06/2001 | WO2001092202A1 Il-8 receptor antagonists |
| 12/06/2001 | WO2001091797A2 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds |
| 12/06/2001 | WO2001091787A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 12/06/2001 | WO2001091536A2 Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens |
| 12/06/2001 | WO2001091535A2 A combination kit used in the treatment of malaria containing chloroquine and 3-(1-(((4-((6-methoxy-8-quinolinyl)amino)pentyl)amino)-ethylidene)-dihydro-2(3h)furanone enthält |
| 12/06/2001 | WO2001025257A3 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery |
| 12/06/2001 | WO2001010847A8 Novel integrin receptor antagonists |
| 12/06/2001 | US20010049142 A rapid, simple-to-use method to differentiate nondividing cells by fusing two different cells and then purifying them without antibiotic or metabolic selection; kits with two nontoxic dyes and instructions; antitumor agents |
| 12/06/2001 | US20010049122 For reducing inflammation, for treating an autoimmune disease, for enhancing transplantation of tissue grafts, increasing antitumor immunity, and inhibiting viral and parasitic infections |
| 12/06/2001 | CA2411323A1 Il-8 receptor antagonists |
| 12/06/2001 | CA2410935A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 12/06/2001 | CA2410903A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 12/06/2001 | CA2410643A1 Hygromycin a derivatives for the treatment of bacterial and protozoal infections |
| 12/06/2001 | CA2410630A1 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds |
| 12/06/2001 | CA2410543A1 Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens |
| 12/06/2001 | CA2410084A1 Transporters and ion channels |
| 12/06/2001 | CA2410051A1 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes |
| 12/06/2001 | CA2409311A1 Regulators of apoptosis |
| 12/05/2001 | EP1160252A1 Avermectin derivatives |
| 12/05/2001 | EP1160240A1 Guanylhydrazones for treating inflammatory conditions |
| 12/05/2001 | EP1158993A1 Bacterial membrane fractions with adjuvant effect |
| 12/05/2001 | EP1158986A1 Protease inhibitors |
| 12/05/2001 | EP0814815A4 Poly(hydroxy acid)/polymer conjugates for skin applications |
| 12/05/2001 | CN1325388A Aza-cyclodepsipeptides and their use as antiparasitics |
| 12/05/2001 | CN1325311A Vaccine against sexually transmitted diseases |
| 12/05/2001 | CN1325299A Orally administered controlled drug delivery system providing temporal and spatial control |
| 12/04/2001 | US6326008 Toxoplasma gondii antigens, the preparation thereof and the use thereof |
| 12/01/2001 | CA2347276A1 I g e-dependent histamine-releasing factor (hrf) receptor, hrf-binding peptides and nucleic acids encoding the same, and uses thereof |
| 11/29/2001 | WO2001090334A2 Drug metabolizing enzymes |
| 11/29/2001 | WO2001090159A2 Compositions and methods for delivery of a molecule into a cell |
| 11/29/2001 | WO2001090129A2 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono and disaccharide-base compounds |
| 11/29/2001 | WO2001090075A1 Compositions for controlling animal ectoparasites |
| 11/29/2001 | WO2001089497A2 Praziquantel compositions for treating diseases due to sarcocystis, neospora, toxoplasma and isospora |
| 11/29/2001 | WO2001049305A3 Process for obtaining thylakoids from plants, pure thylakoids and use thereof |
| 11/29/2001 | WO2000041473A3 Use of 3-isoxazolidinones and hydroxylamine acids for the treatment of infections |
| 11/29/2001 | US20010046985 Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection |